The potential of bacteriophage therapy in the treatment of paediatric respiratory infections. (December 2022)

• Record Type: Journal Article
• Authors: Jones, J.D.; Varghese, D.; Pabary, R.; Langley, R.J.
• Is Part Of: Paediatric respiratory reviews. Volume 44(2022)
• Page Start: 70
• Page End: 77
• Publication Date: 2022-12
• Subjects: Bacteriophage -- Antibiotic resistance -- Respiratory infections -- Cystic fibrosis; Pediatric respiratory diseases -- Periodicals; Respiratory organs -- Diseases -- Periodicals; Respiratory Tract Diseases -- Periodicals; Respiratory Therapy -- Periodicals; Child -- Periodicals; Appareil respiratoire -- Infections, chez l'enfant -- Périodiques; Appareil respiratoire -- Maladies, chez l'enfant -- Périodiques; 618.922
• DOI: 10.1016/j.prrv.2022.02.001
• Languages: English
• ISSNs: 1526-0542

Abstract

Abstract: The looming antibiotic resistance crisis is forcing clinicians to consider alternative approaches to treating bacterial infections. As the window of use for current antimicrobial agents becomes ever narrower, we consider if looking back will now be the way forward. Conceptually, phage therapy is simple and specific; a targeted treatment to control bacterial overgrowth. In this article we discuss bacteriophage and potential use in future therapy.